Clene Inc — Cash Flow (NASDAQ:CLNN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -18.93 M-34.62 M-39.01 M-30.17 M-21.33 M-18.55 M -18.55 M Cash from investing activities -387 K-1.33 M-10.16 M-1.5 M6.32 M-39 K -39 K Cash from financing activities 69.53 M27.11 M17.25 M42.16 M-1.53 M11.52 M 11.52 M Free cash flow -19.32 M-35.96 M-45.5 M-30.5 M-21.34 M-18.59 M -18.59 M

News

Clene Inc. ten percent owner sells $161k in shares

Clene Inc. ten percent owner sells $256k in shares

FDA grants Clene in-person meeting to discuss ALS drug biomarker data

Clene secures $28 million in registered direct offering for ALS drug

Clene Inc. ten percent owner Ugwumba sells $78k in shares

Ugwumba Chidozie sells Clene Inc. (CLNN) stock worth $73,123

Clene Inc: Ugwumba sells $73k in CLNN stock

Benchmark reiterates Buy rating on Clene stock amid positive biomarker data

Clene stock holds Buy rating at Benchmark as ALS drug nears FDA submission

Clene Inc. (CLNN) Reports Q3 Loss, Lags Revenue Estimates

Oculis Holding AG (OCS) Reports Q3 Loss, Beats Revenue Estimates

C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Beats Revenue Estimates